Table 1 Distribution of oralfacial neoplasms in Mulago Uganda (UG) and Muhimbili Tanzania (TZ)
Diagnosis | Abbreviation | UG | TZ | % of overall |
|---|---|---|---|---|
Ameloblastoma | AME | 73 | 99 | 9.23 |
Odontogenic myxoma | MYX | 6 | 15 | 1.13 |
Ameloblastic fibroma | AMEF | 1 | 3 | 0.21 |
Adenomatoid odontogenic tumour | AOT | 1 | 1 | 0.11 |
Odontoma | ODT | 1 | 0 | 0.05 |
Odontogenic fibroma | ODF | 0 | 5 | 0.27 |
Malignant ameloblastoma | MAME | 0 | 1 | 0.05 |
Fibroma | FIB | 88 | 48 | 7.30 |
Ossifying fibroma | OF | 0 | 2 | 0.11 |
Cementifying fibroma | CF | 4 | 5 | 0.48 |
Chondroma | CHD | 1 | 2 | 0.16 |
Osteoma | OST | 5 | 4 | 0.48 |
Osteo sarcoma | OSS | 2 | 5 | 0.38 |
Fibro sarcoma | FIS | 4 | 1 | 0.27 |
Chondrosarcoma/Chondro myxoid fibro sarcoma | CHS | 7 | 1 | 0.43 |
Myxoid sarcoma | MYXS | 1 | 0 | 0.05 |
Round cell carcinoma | RCS | 0 | 1 | 0.05 |
Burkitts lymphoma | BUR | 291 | 91 | 20.54 |
Non Hodgkin's lymphoma | NHL | 11 | 6 | 0.91 |
Histiocytic lymphoma | HLH | 1 | 0 | 0.05 |
Centroblastic polymorphic lymphoma | CPL | 0 | 1 | 0.05 |
Squamous cell carcinoma | SCCa | 190 | 93 | 15.22 |
Anaplastic carcinoma | ACa | 9 | 8 | 0.86 |
Un/Poorly differentiated carcinoma | UCa | 19 | 0 | 1.02 |
Nasopharyngeal carcinoma | NPCa | 1 | 0 | 0.05 |
Non keratinizing carcinoma of tonsil | NKTca | 0 | 1 | 0.05 |
Verrucous carcinoma | Vca | 3 | 3 | 0.32 |
Bassal cell carcinoma | BCCa | 0 | 1 | 0.05 |
Adenoma | ADN | 16 | 3 | 1.02 |
Pleomorphic adenoma | PLA | 43 | 49 | 4.95 |
Monomorphic adenoma | MOA | 0 | 1 | 0.05 |
Oxyphill cell adenoma | OCA | 3 | 0 | 0.16 |
Adeno carcinoma | ADCa | 22 | 10 | 1.72 |
Adenocystic carcinoma (Cylindroma) | ACCa | 14 | 5 | 1.02 |
Salivary gland carcinoma | SGCa | 2 | 1 | 0.16 |
Mucous secreting carcinoma | MSCa | 4 | 0 | 0.22 |
Muco epidermoid carcinoma | MECa | 5 | 4 | 0.48 |
Carcinoma ex pleomorphic adenoma | CaPLA | 1 | 0 | 0.05 |
Haemagio pericytoma | HAP | 2 | 2 | 0.22 |
Kaposis sarcoma | KS | 365 | 44 | 21.98 |
Haemagio sarcoma | HAS | 0 | 1 | 0.05 |
Granular cell myoblastoma | GCM | 6 | 0 | 0.32 |
Leiomyoma | LEI | 0 | 1 | 0.05 |
Rhabdomyosarcoma | RHS | 8 | 1 | 0.48 |
Lymphagioma | LPH | 11 | 1 | 0.65 |
Lymphagiosarcoma | LPHS | 0 | 1 | 0.05 |
Lipoma | LIP | 19 | 10 | 1.56 |
Liposarcoma | LIS | 1 | 1 | 0.11 |
Melanotic prognoma | MEP | 1 | 0 | 0.05 |
Melanoma | MEL | 5 | 2 | 0.38 |
Hamartoma | HAM | 4 | 2 | 0.32 |
Papilloma | PAP | 35 | 22 | 3.06 |
Neurofibroma | NEF | 10 | 2 | 0.65 |
Schwarnoma | SCH | 0 | 2 | 0.11 |
Mesenchynoma | MSA | 0 | 1 | 0.05 |
Calcifying Epithelioma of Malherbe | CEM | 1 | 1 | 0.11 |
Chodro Syrigoma | CHSY | 1 | 0 | 0.05 |
Retinoblastoma | REBA | 0 | 1 | 0.05 |
TOTAL | Â | 1298 | 565 | Â |